Skip to main content
Parnax Lab Limited logo

Parnax Lab Limited — Investor Relations & Filings

Ticker · 506128 ISIN · INE383L01019 BSE.NS Manufacturing
Filings indexed 286 across all filing types
Latest filing 2024-06-04 Regulatory Filings
Country IN India
Listing BSE.NS 506128

About Parnax Lab Limited

https://naxparlab.com

Parnax Lab Limited specializes in the development and large-scale manufacturing of pharmaceutical formulations, with a primary focus on liquid orals, ointments, creams, and gels. The company operates advanced production facilities compliant with international quality benchmarks, including WHO-GMP standards. It functions as a contract development and manufacturing organization (CDMO), providing end-to-end solutions from formulation development to commercial production for global and domestic healthcare brands. The product range encompasses diverse therapeutic areas such as dermatology, gastrointestinal health, and pediatric care. By integrating modern technology with rigorous quality control processes, the company ensures the delivery of high-stability medicinal products. Its operations are supported by a dedicated research and development wing focused on optimizing delivery systems and enhancing product efficacy for various clinical applications.

Recent filings

Filing Released Lang Actions
Please find enclosed herewith the Postal Ballot Notice, for seeking approval of Shareholders of the Company on the mentioned resolutions through remote E-Voting process only.
Regulatory Filings
2024-06-04 English
Kindly find attached herewith the Secretarial Compliance Report under Regulation 24A of SEBI (LODR), Regulations, 2015.
Regulatory Filings
2024-05-30 English
Kindly find enclosed therewith the Audited Standalone and Consolidated Financial Results for the Quarter and Year Ended March 31, 2024.
Regulatory Filings
2024-05-30 English
Pursuant to the provisions of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) 2015, we wish to inform you that the Board of Directors of the ....
Regulatory Filings
2024-05-30 English
PARNAX LAB LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 30/05/2024 ,inter alia, to consider and approve Pursuant to Regulation 29 of Listing ....
Regulatory Filings Classification · 100% confidence The document text is extremely short (only 96 characters) and contains only a digital signature line with no substantive content or financial data. There is no indication of any report, announcement, or detailed information. Given the lack of content, this document does not fit any specific report category and defaults to Regulatory Filings (RNS) as a fallback category for miscellaneous filings without substantive content.
2024-05-22 English
Please find enclosed herewith the Certificate as per Regulation 40(9), of LODR Regulation, 2015 for the year ended March 31, 2024. Kindly take the same on your record.
Regulatory Filings
2024-04-12 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.